• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Oct 21.
doi: 10.1002/jmv.26618. Online ahead of print.
Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2


Srujana Mohanty[SUP] 1 [/SUP], Akshatha Ravindra[SUP] 1 [/SUP], Kavita Gupta[SUP] 1 [/SUP], Vinaykumar Hallur[SUP] 1 [/SUP], Bijayini Behera[SUP] 1 [/SUP], Ashoka Mahaptra[SUP] 1 [/SUP], Swarnatrisha Saha[SUP] 1 [/SUP], Jai Ranjan[SUP] 1 [/SUP], Poesy Payal[SUP] 1 [/SUP], Monalisa Mohanty[SUP] 1 [/SUP], Sutapa Rath[SUP] 1 [/SUP], Baijayantimala Mishra[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: The unprecedented demand for testing for the ongoing coronavirus disease-2019 (COVID-19) pandemic caused by SARS-CoV-2 has led to an acute shortage and limited availability of test reagents for which pooling of samples has been recommended in areas with low prevalence. Considering the possibility of dilution factor in pool testing, an attempt was made to find out possibility of any true positive sample/s in pools with late amplification.
Methods: The study was conducted on samples received from various collection centres in different districts of Odisha as well as from patients attending the screening clinic or admitted in COVID ward of the hospital. Nasal/nasopharyngeal/throat swabs received in viral transport media in cold chain were subjected to RT-PCR testing in a Biosafety Laboratory level-2 by including uniform volume of 4 units (samples) per pool. All confirmed and probable positive pools in screening assay were de-convoluted and individual samples tested for confirmatory assay.
Result: Inclusion of an additional criteria of probable positive pool (Ct value >35 with non-sigmoid amplification curve or showing a line of amplification towards the end of the cycle) yielded 39 (15.5%) more true positive samples out of a total of 251 positive samples that would otherwise have been missed if only the classical criteria of positive (Ct within 35 with proper sigmoid curve) had been considered.
Conclusion: The study highlights the importance of considering any indication of late amplification in the RT-PCR test to label a pool as positive to avoid missing any true positive sample in the pool. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Real time polymerase chain reaction; SARS-CoV-2; pool test.
 
Back
Top Bottom